Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.

Lumira News

Double Bottom Line Challenge Update: Lumira Ventures gives to five additional initiatives in our communities to support those in need during the COVID-19 crisis.

May 29, 2020
Over the past several weeks, we have seen a number of provinces and states relax restrictions and open up further. Combined with the start of summer, this has caused many to ease on social... Learn More

IMV Announces Proposed $22.3 Million Private Placement

May 1, 2020
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced its intention to complete a private placement (the “Private... Learn More

Edesa Biotech and Light chain Bioscience Sign License Agreement to Develop Treatments for COVID-19 Pneumonia and Other Disorders

April 20, 2020
TORONTO, ON / ACCESSWIRE / April 20, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, today announced a strategic agreement with Light Chain Bioscience (a brand of... Learn More

Engage Therapeutics’ Phase 2b StATES Study Meets Primary Endpoint

March 12, 2020
SUMMIT, N.J. (GLOBE NEWSWIRE) -- Engage Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing an orally inhaled therapy designed to terminate an active epileptic... Learn More

MORE NEWS

Team Lumira

Our investment team of 9 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.

MEET THE TEAM
Image

Philanthropy

Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.

LEARN MORE

  • “Lumira’s philanthropic vision of leveraging research, resources and knowledge to improve the lives of patients will strengthen St. Michael’s ability to accelerate the pace.”

    Dr. Arthur Slutsky | Vice-President
    Vice-President of Research at St. Michael’s Hospital

  • “Lumira’s model provides a new pathway for philanthropy to partner with investors in advancing healthcare innovation.”

    Barbara Grantham | President & Ceo
    VGH & UBC Hospital Foundation

  • “This distinctive approach to supporting innovation is very creative, very much needed and very much appreciated by Princess Margaret and University Health Network.”

    Paul Alofs | President & Ceo
    Princess Margaret Cancer Foundation

Contact Us

Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.

Image

Toronto

141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223

Image

Montreal

Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927

Image

Vancouver

1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156

Image

Boston

303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868